Alcobra Competitors and Similar CompaniesClear all

Paion's competitors and similar companies include Affimed N.V..
Paion
Paion
PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs.
Affimed N.V.
Affimed N.V.
Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies.
Founding Date
Founding Date
2000
Founding Date
2000
Type
Type
Public
Type
Public
Tags
Locations
Locations
Aachen, DE HQ
Odense, DK
Hoofddorp, NL
Richmond, GB
Locations
Heidelberg, DE HQ
Employees
Employees
3218% decrease
Employees
76
Valuation ($)
Valuation ($)
49.7 m
Valuation ($)
52.5 m

Financial

Revenue (est.)
Revenue (est.)
€33.2m (FY, 2022)
Revenue (est.)
€8.3m (FY, 2023)
Cost of goods
Cost of goods
€382k (FY, 2022)
Cost of goods
N/A
Gross profit
Gross profit
€33.4m (FY, 2022)
Gross profit
€13m (FY, 2023)
Net income
Net income
(€579k) (FY, 2022)
Net income
(€105.9m) (FY, 2023)
For sources of this data, please see the company profile

View Company Profiles

Affimed N.V.
HQ
Heidelberg, DE
Employees
76

Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies.

View company